Sunday, August 16, 2026
26.2 C
Bengaluru

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief Business Officer – Vaccines. With more than 30 years of leadership experience spanning vaccines, pharmaceuticals, specialty products, and commercial strategy, he brings a strong global perspective and a proven ability to drive growth across diverse markets.

In his new capacity, Manishkumar will oversee the company’s vaccines business across India as well as international markets, including Europe and the United States. His mandate includes enhancing commercial performance, building strategic partnerships, and guiding sustainable business expansion.

Throughout his career, Manishkumar has demonstrated consistent success in scaling operations, strengthening market presence, and delivering measurable results across global healthcare and vaccine markets.

Biological E. looks forward to leveraging his leadership to accelerate growth and strengthen its position in both domestic and international vaccine markets.

MedicinMan congratulates Manishkumar Munot and wishes him continued success in this role.

Hot this week

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...

Topics

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...

Platforms Are Owning the Patient While Pharma Waits

The future of experimental medicine is not simply a...

Samit Mehta has been appointed Chief Operating Officer (COO) of Emcure Pharmaceuticals Ltd.

Samit Mehta brings extensive experience in healthcare leadership, business...
spot_img

Related Articles

spot_imgspot_img